Comparison of hepatic resection and transarterial chemoembolization for solitary hepatocellular carcinoma

Table 3 Univariate analyses show factors of overall survival

Variables	n	Overall survival rate
	499	P value
Age < 60 (yes/no)	341/158	0.041
Gender (M/F)	372/127	0.596
BMI ≥ 26 (yes/no)	72/427	0.268
Cause of liver diseases (HBV/HCV/no/others)	449/11/15/24	0.779
Child-Pugh Score (A/B)	384/115	0.897
ECOG score (0/1/2)	372/68/59	0.594
PHT (yes/no)	425/74	< 0.001
ALB ≥ 35 g/L (yes/no)	275/224	0.221
Platelets ≥ 100 × 109/L (yes/no)	177/322	0.923
HB ≥ 120 g/L (yes/no)	331/168	0.602
Creatinine ≥ 100 μmol/L (yes/no)	49/450	0.675
NLR ≥ 4 (yes/no)	269/230	< 0.001
AFP level (1-400/400-800/800-1200/ > 1200 ng/mL)	256/37/28/178	0.218
Tumor diameter > 6 cm (yes/no)	306/193	< 0.001
Obvious arterial phase enhancement (yes/no)	397/102	0.361
Diagnostic method (enhanced CT/MRI/biopsy)	410/63/26	0.587
Therapy (liver resection/TACE)	218/281	0.437

BMI: Body mass index; HBV: Hepatitis B virus; HCV: Hepatitis C virus; MELD: Model for end-stage liver disease; NLR: Neutrophil-lymphocyte ratio; AFP: Alpha-fetoprotein; TACE: Transarterial chemoembolization; ALB: Albumin; CT: Computed tomography; MRI: Magnetic resonance imaging; M: Male; F: Female.